Empagliflozin

Common brands: Jardiance, Metformin Hydrochloride, Metformin, Aspirin 325, Aspirin 81

Top reporter: Boehringer Ingelheim Pharmaceuticals, Inc.

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]GLP-1 Receptor Agonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Insulin Analog [EPC]Loop Diuretic [EPC]
64,248
Total Reports
33,612
Serious Reports
3,196
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.97%)

Patient Demographics

Male
30,507
Female
26,426

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Empagliflozin.

# Reaction Reports % of Total
1 DIABETIC KETOACIDOSIS 3,825
6.4%
2 NAUSEA 3,400
5.7%
3 BLOOD GLUCOSE INCREASED 3,125
5.3%
4 DIARRHOEA 3,024
5.1%
5 WEIGHT DECREASED 2,841
4.8%
6 FATIGUE 2,737
4.6%
7 OFF LABEL USE 2,610
4.4%
8 VOMITING 2,561
4.3%
9 DIZZINESS 2,528
4.3%
10 DRUG INEFFECTIVE 2,273
3.8%
11 DYSPNOEA 2,228
3.7%
12 FUNGAL INFECTION 2,098
3.5%
13 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2,005
3.4%
14 URINARY TRACT INFECTION 1,904
3.2%
15 HEADACHE 1,797
3.0%
16 ACUTE KIDNEY INJURY 1,664
2.8%
17 ASTHENIA 1,557
2.6%
18 DEHYDRATION 1,504
2.5%
19 KETOACIDOSIS 1,486
2.5%
20 DEATH 1,473
2.5%
21 MALAISE 1,421
2.4%
22 DECREASED APPETITE 1,401
2.4%
23 HYPOTENSION 1,343
2.3%
24 PAIN 1,343
2.3%
25 FALL 1,300
2.2%
26 COUGH 1,239
2.1%
27 PRURITUS 1,230
2.1%
28 GLYCOSYLATED HAEMOGLOBIN INCREASED 1,198
2.0%
29 RASH 1,174
2.0%
30 ARTHRALGIA 1,164
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.